Joint Formulary & PAD

Paracetamol - Pyrexia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Preferred
 

Status 2

Green (see narrative)
Formulations :
  • Effervescent tablets
  • Soluble tablets
  • Suppositories
Associated Icons :
Restrictions / Comments :
Important
Reserve for patients who cannot swallow solid dose forms. Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets.
 

Status 3

Green (see narrative)
Formulations :
  • Oral suspension
Associated Icons :
Restrictions / Comments :
Important
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms. Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
 

Status 4

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :
Important
Prescribe in milligrams for doses <1g Review infusion prescriptions after 48-72 hours. Note risk of overdose with IV paracetamol.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Paracetamol
Indication :
Pyrexia
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
4

Other Indications

Below are listed other indications that Paracetamol is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pyrexia.

  • No records returned.

Committee Recommendations (0)

  • No records returned.